All stock lists
International Stem Cell CORP (OTC:ISCO)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.14-0.01 (-6.67%)
Insider Score
––Not scored
ISCO Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
ISCO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 2.67 M | 2.31 M | 2.15 M | 2.37 M | 2.45 M | 2.13 M |
| Revenue Growth (YoY) | 9.32 % | 8.74 % | -11.90 % | 8.72 % | 4.98 % | 0.00 % |
| Cost of Revenue | 1.23 M | 954.00 K | 1.07 M | 1.05 M | 927.00 K | 992.00 K |
| Gross Profit | 1.45 M | 1.36 M | 1.09 M | 1.32 M | 1.52 M | 1.14 M |
| SG&A Expense | 1.34 M | 1.40 M | 1.23 M | 1.07 M | 1.19 M | 1.17 M |
| R&D Expense | 155.00 K | 156.00 K | 177.00 K | 158.00 K | 162.00 K | 187.00 K |
| Operating Expenses | 1.37 M | 1.55 M | 1.40 M | 1.23 M | 1.35 M | 1.35 M |
| Operating Income | 76.00 K | -190.00 K | -313.00 K | 94.00 K | 167.00 K | -215.00 K |
| Pretax Income | -71.00 K | -220.00 K | -348.00 K | 57.00 K | 129.00 K | -256.00 K |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -71.00 K | -220.00 K | -348.00 K | 57.00 K | 129.00 K | -256.00 K |
| EPS (Basic) | -0.01 | -0.03 | -0.03 | 0.01 | 0.01 | -0.03 |
| EPS (Diluted) | -0.01 | -0.03 | -0.03 | 0.01 | 0.01 | -0.03 |
| Shares Outstanding | 8.00 M | 8.00 M | 8.00 M | 8.00 M | 8.00 M | 8.00 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.